These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Public Health Crises and the Human Subjects of Biomedical Research: A Focus on COVID-19. Sher T; Wright RS Mayo Clin Proc; 2020 Jun; 95(6):1130-1131. PubMed ID: 32376104 [No Abstract] [Full Text] [Related]
43. Will Virtual Teaching Continue After the COVID-19 Pandemic? Marques da Silva B Acta Med Port; 2020 Jun; 33(6):446. PubMed ID: 32378509 [No Abstract] [Full Text] [Related]
44. Clinical trials and the COVID-19 pandemic. Retsas S Hell J Nucl Med; 2020; 23(1):4-5. PubMed ID: 32361715 [TBL] [Abstract][Full Text] [Related]
45. COVID-19 Hits Cancer Research Funding. Cancer Discov; 2020 Jun; 10(6):756. PubMed ID: 32332087 [TBL] [Abstract][Full Text] [Related]
46. Safeguard research in the time of COVID-19. Nat Med; 2020 Apr; 26(4):443. PubMed ID: 32242126 [No Abstract] [Full Text] [Related]
47. Impact of the COVID-19 pandemic on surgical services: early experiences at a nominated COVID-19 centre. McBride KE; Brown KGM; Fisher OM; Steffens D; Yeo DA; Koh CE ANZ J Surg; 2020 May; 90(5):663-665. PubMed ID: 32259337 [No Abstract] [Full Text] [Related]
48. Lead the way or leave the way: leading a Department of Orthopedics through the COVID-19 pandemic. Mauffrey C; Trompeter A Eur J Orthop Surg Traumatol; 2020 May; 30(4):555-557. PubMed ID: 32303841 [No Abstract] [Full Text] [Related]
49. Editorial: Clinical trial design in the era of COVID-19. Begg CB; Gonen M; Heitjan DF Clin Trials; 2020 Oct; 17(5):465-466. PubMed ID: 32650671 [No Abstract] [Full Text] [Related]
50. Single-Institution Experience in Clinical Trials During the COVID-19 Pandemic in Spain: Not So Bad After All? Rodriguez-Otero P; Reis J; Alfonso-Pierola A; Salas-Benito D; Giraldez M; Azanza JR; Ponz-Sarvise M JCO Glob Oncol; 2020 Jun; 6():904-905. PubMed ID: 32589463 [No Abstract] [Full Text] [Related]
51. Keeping up with studies on covid-19: systematic search strategies and resources. Shokraneh F BMJ; 2020 Apr; 369():m1601. PubMed ID: 32327431 [No Abstract] [Full Text] [Related]
52. Challenges and Opportunities for the Biotechnology Research Community during the Coronavirus Pandemic. Rosales-Mendoza S; Comas-GarcĂa M; Korban SS Trends Biotechnol; 2020 Aug; 38(8):823-824. PubMed ID: 32423724 [TBL] [Abstract][Full Text] [Related]
53. How an immunologist pivoted to tackle COVID-19. Couzin-Frankel J Science; 2020 Oct; 370(6516):514-515. PubMed ID: 33122364 [No Abstract] [Full Text] [Related]
55. A planetary health perspective on COVID-19: a call for papers. Brown A; Horton R Lancet; 2020 Apr; 395(10230):1099. PubMed ID: 32247382 [No Abstract] [Full Text] [Related]
56. Clinical Trials for COVID-19: Can we Better Use the Short Window of Opportunity? Eichler HG; Cavaleri M; Enzmann H; Scotti F; Sepodes B; Sweeney F; Vamvakas S; Rasi G Clin Pharmacol Ther; 2020 Oct; 108(4):730-733. PubMed ID: 32407539 [TBL] [Abstract][Full Text] [Related]
57. Rapid mobilisation of research in response to covid-19: a paradigm for the future. James M; Ford GA; Robinson T; Al-Shahi Salman R BMJ; 2020 May; 369():m2155. PubMed ID: 32471855 [No Abstract] [Full Text] [Related]
58. How the COVID-19 pandemic highlights the necessity of animal research. Genzel L; Adan R; Berns A; van den Beucken JJJP; Blokland A; Boddeke EHWGM; Bogers WM; Bontrop R; Bulthuis R; Bousema T; Clevers H; Coenen TCJJ; van Dam AM; Deen PMT; van Dijk KW; Eggen BJL; Elgersma Y; Erdogan I; Englitz B; Fentener van Vlissingen JM; la Fleur S; Fouchier R; Fitzsimons CP; Frieling W; Haagmans B; Heesters BA; Henckens MJAG; Herfst S; Hol E; van den Hove D; de Jonge MI; Jonkers J; Joosten LAB; Kalsbeek A; Kamermans M; Kampinga HH; Kas MJ; Keijer JA; Kersten S; Kiliaan AJ; Kooij TWA; Kooijman S; Koopman WJH; Korosi A; Krugers HJ; Kuiken T; Kushner SA; Langermans JAM; Lesscher HMB; Lucassen PJ; Lutgens E; Netea MG; Noldus LPJJ; van der Meer JWM; Meye FJ; Mul JD; van Oers K; Olivier JDA; Pasterkamp RJ; Philippens IHCHM; Prickaerts J; Pollux BJA; Rensen PCN; van Rheenen J; van Rij RP; Ritsma L; Rockx BHG; Roozendaal B; van Schothorst EM; Stittelaar K; Stockhofe N; Swaab DF; de Swart RL; Vanderschuren LJMJ; de Vries TJ; de Vrij F; van Wezel R; Wierenga CJ; Wiesmann M; Willuhn I; de Zeeuw CI; Homberg JR Curr Biol; 2020 Sep; 30(18):R1014-R1018. PubMed ID: 32961149 [TBL] [Abstract][Full Text] [Related]
59. The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world? Guerin PJ; Singh-Phulgenda S; Strub-Wourgaft N F1000Res; 2020; 9():225. PubMed ID: 32566139 [TBL] [Abstract][Full Text] [Related]
60. Covid-19: politicisation, "corruption," and suppression of science. Abbasi K BMJ; 2020 Nov; 371():m4425. PubMed ID: 33187972 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]